Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$15.30 USD
-0.38 (-2.42%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $15.32 +0.02 (0.13%) 4:38 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.82 | 2.83% |
Earnings Summary
For their last quarter, Urogen Pharma (URGN) reported earnings of -$0.97 per share, missing the Zacks Consensus Estimate of -$0.93 per share. This reflects a negative earnings surprise of 4.30%. Look out for URGN's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.82 per share, reflecting a year-over-year increase of 20.39%.
Earnings History
Price & Consensus
Zacks News for URGN
Urogen Pharma (URGN) Expected to Beat Earnings Estimates: Should You Buy?
URGN: What are Zacks experts saying now?
Zacks Private Portfolio Services